Biogen
Price & Volume
Stats
See more52W Range | $121.05-$205.97 |
Market Cap | $29B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $9.9B |
Revenue Growth (YoY) | 1.9% |
Gross Profit (12 Mos) | $7.8B |
Diluted EPS | $9.31 |
News
See moreYahoo Finance • 8 days ago
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
Yahoo Finance • 11 days ago
Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
Yahoo Finance • 12 days ago
Goldman Sachs sets new Biogen stock price target on bold Alzheimer's bet
Yahoo Finance • 15 days ago
Biogen Shares Jump 10% After Advancing Alzheimer's Tau Drug
About
CEO | Mr. Christopher A. Viehbacher |
CFO | Ms. Robin C. Kramer |
Address | 225 Binney Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 7,500 |